CLASS II ONGOING Device recall · Reported 13 Apr 2022 · FDA Enforcement Report

Alinity m HBV AMP Kit (US and CE) recalled by Abbott Molecular

Abbott Molecular is recalling Alinity m HBV AMP Kit (US and CE), distributed in 14 states. The recall was initiated on 4 Mar 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesList Numbers: 1) 08N47-095 (US); Lots: 519756, 523799, and 524361, Updated to add: 381583, 529391, 529687, 530273, 531598; 2) 08N47-090 (CE); Lots: 519755, 520957, 522137, 523798, and 524059, Updated to add: 380963, 380979, 381021, 529378, 529686, 530272, 531189, 531596
Quantity recalled4966 kits, updated 101/17/2023

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0884-2022
FDA event ID
89757
Recalling firm
Abbott Molecular, Des Plaines, IL
Classification
Class II
Status
Ongoing
Recall initiated
4 Mar 2022
FDA classified
6 Apr 2022
Reported
13 Apr 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

4 Mar 2022Recall initiated by company
6 Apr 2022Classified by FDA+33 days
13 Apr 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential for misquantitation high results for negative samples.

Product as listed by the FDA

Alinity m HBV AMP Kit (US and CE)

Where it was distributed

US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam

ArizonaCaliforniaIllinoisIndianaMassachusettsMichiganMissouriNew HampshireNew JerseyNew YorkOhioSouth DakotaTexasVirginia

Questions about this recall

Why was it recalled?

There is a potential for misquantitation high results for negative samples.

Which lots are affected?

List Numbers: 1) 08N47-095 (US); Lots: 519756, 523799, and 524361, Updated to add: 381583, 529391, 529687, 530273, 531598; 2) 08N47-090 (CE); Lots: 519755, 520957, 522137, 523798, and 524059, Updated to add: 380963, 380979, 381021, 529378, 529686, 530272, 531189, 531596

Where was it sold?

US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 89757
ReportedClassRecallCompanyReasonWhere
CLASS IIAlinity m HBV Application Specification File (US and CE) recalledAbbott MolecularOther14 states

More recalls from Abbott Molecular

All 36

Other Other Medical Devices recalls

All 13,908